Cargando…
SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
SIRT1 has been considered as a tumor promoter because of its increased expression in some types of cancers and its role in inactivating proteins that are involved in tumor suppression and DNA damage repair. However, recent studies demonstrated that SIRT1 levels are reduced in some other types of can...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631220/ https://www.ncbi.nlm.nih.gov/pubmed/19173036 |
_version_ | 1782163919028092928 |
---|---|
author | Deng, Chu-Xia |
author_facet | Deng, Chu-Xia |
author_sort | Deng, Chu-Xia |
collection | PubMed |
description | SIRT1 has been considered as a tumor promoter because of its increased expression in some types of cancers and its role in inactivating proteins that are involved in tumor suppression and DNA damage repair. However, recent studies demonstrated that SIRT1 levels are reduced in some other types of cancers, and that SIRT1 deficiency results in genetic instability and tumorigenesis, while overexpression of SIRT1 attenuates cancer formation in mice heterozygous for tumor suppressor p53 or APC. Here, I review these recent findings and discuss the possibility that activation of SIRT1 both extends lifespan and inhibits cancer formation. |
format | Text |
id | pubmed-2631220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-26312202009-01-27 SIRT1, Is It a Tumor Promoter or Tumor Suppressor? Deng, Chu-Xia Int J Biol Sci Review SIRT1 has been considered as a tumor promoter because of its increased expression in some types of cancers and its role in inactivating proteins that are involved in tumor suppression and DNA damage repair. However, recent studies demonstrated that SIRT1 levels are reduced in some other types of cancers, and that SIRT1 deficiency results in genetic instability and tumorigenesis, while overexpression of SIRT1 attenuates cancer formation in mice heterozygous for tumor suppressor p53 or APC. Here, I review these recent findings and discuss the possibility that activation of SIRT1 both extends lifespan and inhibits cancer formation. Ivyspring International Publisher 2009-01-21 /pmc/articles/PMC2631220/ /pubmed/19173036 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. |
spellingShingle | Review Deng, Chu-Xia SIRT1, Is It a Tumor Promoter or Tumor Suppressor? |
title | SIRT1, Is It a Tumor Promoter or Tumor Suppressor? |
title_full | SIRT1, Is It a Tumor Promoter or Tumor Suppressor? |
title_fullStr | SIRT1, Is It a Tumor Promoter or Tumor Suppressor? |
title_full_unstemmed | SIRT1, Is It a Tumor Promoter or Tumor Suppressor? |
title_short | SIRT1, Is It a Tumor Promoter or Tumor Suppressor? |
title_sort | sirt1, is it a tumor promoter or tumor suppressor? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631220/ https://www.ncbi.nlm.nih.gov/pubmed/19173036 |
work_keys_str_mv | AT dengchuxia sirt1isitatumorpromoterortumorsuppressor |